Matthew Perrone, WJTV 12 News

Matthew Perrone

WJTV 12 News

Washington, DC, United States

Contact Matthew

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • WJTV 12 News

Recent articles by Matthew:

Vaping company Juul cuts 400 jobs amid growing setbacks

WASHINGTON (AP) — Embattled vaping company Juul Labs announced hundreds of layoffs Thursday as the company weathers lawsuits, government bans and increasing competition for its electronic cigarettes. Juul said it has obtained new financing to stay in business and continue operations, which includes challenging plans by the Food and Drug Administration to ban its products. […] → Read More

FDA targets illegal nicotine gummies in new warning letter

WASHINGTON (AP) — Federal regulators on Thursday issued a first-of-a-kind warning to the maker of nicotine gummies, saying the illegal candies pose a growing risk to teenagers and younger children. The Food and Drug Administration said the fruit-flavored gummies from Florida manufacturer VPR Brands could cause nicotine poisoning or even death if eaten by small […] → Read More

FDA advisers recommend updating COVID booster shots for fall

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Advisers to the Food and Drug Administration wrestled with how to modify doses now when there’s no way to know how the rapidly […] → Read More

Abbott restarts baby formula plant linked to contamination

WASHINGTON (AP) — Abbott Nutrition has restarted production at the Michigan baby formula factory that has been closed for months due to contamination, the company said Saturday, taking a step toward easing a nationwide supply shortage expected to persist into the summer. The February shutdown of the largest formula factory in the country led to […] → Read More

FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities […] → Read More

Change at the top for Biogen after Alzheimer’s drug flops

Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer’s drug Aduhelm less than a year after the medication’s launch triggered a backlash from experts, doctors and insurers. CEO Michel Vounatsos will continue to lead the Biogen until a successor is found, the company announced Tuesday. Vounatsos joined the company in 2016 […] → Read More

FDA issues plan to ban menthol in cigarettes, cigars

WASHINGTON (AP) — The U.S. government on Thursday released its long-awaited plan to ban menthol cigarettes and flavored cigars, citing the toll on Black smokers and young people. “The proposed rules would help prevent children from becoming the next generation of smokers and help adult smokers quit,” said Health and Human Services Secretary Xavier Becerra, […] → Read More

Lawmakers scrutinize McKinsey’s opioid, FDA consulting work

WASHINGTON (AP) — House Democrats vowed to continue investigating consulting giant McKinsey’s work with opioid drugmakers after a Wednesday hearing detailed how the firm had advised companies pushing painkillers as well as U.S. health regulators. The hearing before a House committee is part of an ongoing probe into McKinsey’s role in theU.S. opioid crisis that […] → Read More

New COVID-19 antibody drug OK’d to protect most vulnerable

WASHINGTON (AP) — Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. Antibody drugs have been a standard treatment for treating COVID-19 infections for over a year. But the AstraZeneca antibody drug cleared by the Food and Drug […] → Read More

Final US hurdle for Merck’s COVID-19 pill: FDA panel review

WASHINGTON (AP) — An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will scrutinize data on the medication from drugmaker Merck. The Food and Drug Administration is asking its outside experts whether the agency should authorize the pill, […] → Read More

FDA: Merck COVID pill effective, experts will review safety

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. The Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and […] → Read More

FDA official explains decision on ‘simplified’ booster shots

WASHINGTON (AP) — The U.S. government’s booster campaign got a lot simpler Friday after Food and Drug Administration officials authorized extra shots of Pfizer and Moderna COVID-19 vaccines for all adults. It replaces a complicated system in which eligibility was based on age, health conditions and other factors. “It’s simplified things, I think significantly over […] → Read More

Pfizer asks US officials to OK promising COVID-19 pill

WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home. The company’s filing comes as new infections are rising once again in the United States, driven mainly by hot spots in […] → Read More

FDA sets stronger safety warnings for breast implants

WASHINGTON (AP) — U.S. health regulators on Wednesday finalized stronger warnings for breast implants, including a new requirement that people receive detailed information about their potential risks and complications before getting them. The Food and Drug Administration announced the new regulations mainly aimed at implant manufacturers, who are also being required to add a boxed […] → Read More

FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters

WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially. The Food and Drug Administration’s decisions mark a big step toward expanding […] → Read More

Efforts grow to stamp out use of parasite drug for COVID-19

WASHINGTON (AP) — Health experts and medical groups are pushing to stamp out the growing use of a decades-old parasite drug to treat COVID-19, warning that it can cause harmful side effects and that there’s little evidence it helps. With a fourth wave of infections, more Americans are turning to ivermectin, a cheap drug used […] → Read More

US officials flag “small” reaction risk with J&J vaccine

WASHINGTON (AP) — Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of a rare but potentially dangerous neurological reaction, U.S. health officials said Monday. The Centers for Disease Control and Prevention said in a statement it has received reports of 100 people who got the shot developing Guillain-Barré syndrome, an immune system […] → Read More

FDA head calls for inquiry into Alzheimer’s drug review

WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug. Dr. Janet Woodcock announced the extraordinary step via Twitter. It’s the latest fallout over last month’s approval of […] → Read More

US extends expiration dates for J&J COVID vaccine by 6 weeks

WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks. The company said a Food and Drug Administration review concluded the shots remain safe and effective for at least 4 1/2 months. In February, the FDA originally authorized J&J’s […] → Read More

COVID-19 hospitalizations tumble among US senior citizens

WASHINGTON (AP) — COVID-19 hospitalizations among older Americans have plunged 80% since the start of the year, dramatic proof the vaccination campaign is working. Now the trick is to get more of the nation’s younger people to roll up their sleeves. The drop-off in severe cases among people 65 and older is so dramatic that […] → Read More